Cannabis Research

Cannabis and PTSD: Veterans Deserve Access to Healing

mm
Add MyCannabis.com to your preferred sources on Google

For decades, U.S. veterans have carried the invisible scars of war. Post-traumatic stress disorder (PTSD) haunts nearly one in three recently discharged service members, manifesting as nightmares, intrusive memories, hypervigilance, and an unrelenting inability to feel joy. Traditional treatment, such as psychotherapy and pharmaceuticals, helps some, but for many, the relief is incomplete. A growing number of veterans are turning to cannabis, not for escape, but for survival. New research published in Psychiatry Research (September 2025) sheds light on why this plant could hold a key to healing, and why policymakers must urgently act to support those who risked everything for their country.

A New Lens on PTSD and Cannabis

Swipe to scroll →

Day-to-Day Pattern With Cannabis Use Without Cannabis Use
PTSD Symptoms Reduced same-day Often worsened
Negative Affect (fear, anger, sadness) Significant decrease Increased next day
Sleep Quality Improved, fewer nightmares Disrupted, frequent nightmares

The study1 examined daily interactions between PTSD symptoms, negative affect, and cannabis use among 74 recently discharged veterans. Using mobile health tracking through the MAVERICK app, researchers followed participants day-to-day, gathering real-time data rather than relying on retrospective surveys.

The results were striking. Cannabis use was associated with same-day reductions in both PTSD symptoms and negative affect, the heavy weight of emotions like fear, sadness, or anger. Conversely, spikes in PTSD symptoms predicted increases in negative affect the following day, showing how trauma perpetuates a cycle of emotional distress.

In simpler terms, when veterans consumed cannabis, they felt better that day. Their symptoms, including emotional flooding, intrusive memories, and unrelenting stress, eased. When they didn’t, the burden often worsened.

This may sound obvious to veterans who have long advocated for medical cannabis access, but having rigorous, daily-level data to back up their lived experiences is groundbreaking. It moves the conversation from anecdote to science, giving policymakers and clinicians no excuse to ignore the evidence.

Negative Affect: The Missing Link

One of the most important contributions of the study lies in its focus on “negative affect.” This term describes not just feeling bad, but experiencing frequent, intense waves of negative emotions that feel impossible to regulate. Research has shown that negative affect plays a central role in both the development and persistence of PTSD. Veterans who feel trapped in cycles of anger, fear, or sadness often turn to coping strategies, sometimes unhealthy ones, to manage those emotions.

Here, cannabis functions as an adaptive tool. Instead of numbing veterans into apathy, the plant may interrupt the feedback loop between PTSD symptoms and emotional overwhelm. For those who struggle with the constant intensity of negative emotions, cannabis may provide not just relief but breathing room and a chance to step out of survival mode.

A Matter of Survival, Not Abuse

Opponents often raise the specter of cannabis misuse, noting that up to 18% of veterans may meet criteria for cannabis use disorder. This concern should not be ignored, but it must be placed in context. Veterans are already disproportionately prescribed opioids, benzodiazepines, and antidepressants; drugs with high risks of dependency and dangerous side effects. By comparison, cannabis presents a far safer risk profile, with no documented lethal overdose threshold.

Moreover, as the study demonstrates, cannabis use among veterans is not simply recreational. It is often a targeted, daily attempt to manage the crushing reality of PTSD. When critics dismiss cannabis as a “crutch,” they erase the lived truth of veterans who use it to sleep through the night, quiet intrusive thoughts, or de-escalate panic attacks. These are not luxuries. They are lifelines.

The Policy Gap

Despite growing evidence, federal law still classifies cannabis as a Schedule I drug, meaning it is considered to have “no accepted medical use.” This designation directly conflicts with research like this study, as well as the experiences of tens of thousands of veterans. It also leaves the Department of Veterans Affairs (VA) in a bind: clinicians cannot legally prescribe or recommend cannabis, even when they know it might help their patients.

The result is cruelly paradoxical. Veterans can risk prison for accessing the very medicine that eases their suffering. Many are forced to navigate patchwork state laws, paying out of pocket for treatment that should be covered as part of their earned healthcare benefits.

If America can send its young men and women to war, it should be willing to provide them with every possible tool for healing when they return. The ongoing criminalization of cannabis for veterans is not just outdated policy; it is a betrayal.

An Urgent Call for Change

The study makes one thing clear: cannabis has therapeutic value for veterans with PTSD. The reductions in daily symptoms and negative affect observed here cannot be brushed aside as a coincidence. They demand attention, further research, and most importantly, policy reform.

Veterans have been at the forefront of advocacy for medical cannabis access, often standing against stigma and bureaucracy to tell their stories. This study validates those stories. It confirms what so many have been saying for years: cannabis helps.

What remains is for lawmakers, healthcare providers, and the VA to act. Expanding research funding, descheduling cannabis at the federal level, and integrating it into veterans’ healthcare are not radical ideas; they are urgent necessities. Until then, veterans will continue to be caught between their trauma and a system that denies them relief.

Conclusion: Science and Policy Must Catch Up

PTSD is not just a diagnosis; it is a daily battle. For too many veterans, that battle continues long after they leave the battlefield. Cannabis, as this study shows, offers a measure of peace in that fight. It is not a panacea, nor is it without risks, but it is a medicine that deserves recognition, respect, and accessibility.

Our veterans deserve more than “thank you for your service.” They deserve science-based policies that prioritize their well-being over outdated stigma. If cannabis can ease their suffering, then denying them access is not just negligence; it is cruelty.

References:

1. Davis, J. P., Saba, S., Leightley, D., Pedersen, E. R., Prindle, J., Castro, C. A., Dilkina, B., Dworking, E., Cantor, J., & Sedano, A. (2025). Daily associations between posttraumatic stress disorder, cannabis use, and negative affect among veterans. Psychiatry Research, 351, Article 116626. https://doi.org/10.1016/j.psychres.2025.116626

Sarah Schwefel is a journalist, research analyst, speaker, and patient advocate. After relocating for access to cannabis for her own health, she became engulphed in the cannabis and hemp industry determined to better help herself and other patients. In 2020, she became certified in endocannabinoid medicine studies from the American Journal of Endocannabinoid Medicine. Sarah uses her expertise to educate and advocate through her writing on various topics including legislation and the benefits plant medicine offers.